This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1995 Jul 1;92(1):9-10.

doi: 10.1161/01.cir.92.1.9.

Is 31P-NMR spectroscopic imaging a viable approach to assess myocardial viability?

PMID: 7788923
DOI: 10.1161/01.cir.92.1.9

Editorial

Is 31P-NMR spectroscopic imaging a viable approach to assess myocardial viability?

G M Pohost. Circulation. 1995.

. 1995 Jul 1;92(1):9-10.

doi: 10.1161/01.cir.92.1.9.

Author

PMID: 7788923
DOI: 10.1161/01.cir.92.1.9

No abstract available

PubMed Disclaimer

Comment on

Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy.
Yabe T, Mitsunami K, Inubushi T, Kinoshita M. Yabe T, et al. Circulation. 1995 Jul 1;92(1):15-23. doi: 10.1161/01.cir.92.1.15. Circulation. 1995. PMID: 7788910

Similar articles

31P nuclear magnetic resonance spectroscopic imaging of regions of remodeled myocardium in the infarcted rat heart.
Friedrich J, Apstein CS, Ingwall JS. Friedrich J, et al. Circulation. 1995 Dec 15;92(12):3527-38. doi: 10.1161/01.cir.92.12.3527. Circulation. 1995. PMID: 8521576
[The evaluation of myocardial protection from ischemia by means of 31P-NMR--the role of changes in myocardial high-energy phosphate levels].
Yokoyama K, Abe Y, Hamada Y, Hongo T, Tabayashi K, Yano M, Konnai T, Kagawa Y, Horiuchi T, Yanagisawa T, et al. Yokoyama K, et al. Nihon Kyobu Geka Gakkai Zasshi. 1984 Feb;32(2):154-61. Nihon Kyobu Geka Gakkai Zasshi. 1984. PMID: 6747351 Japanese. No abstract available.
Assessment of myocardial viability by 31P-MR-spectroscopy and 23Na-MR imaging.
Beer M, Sandstede J, Pabst T, Landschütz W, Harre K, von Kienlin M, Voelker W, Neubauer S, Hahn D. Beer M, et al. MAGMA. 2000 Nov;11(1-2):44-6. doi: 10.1016/s1352-8661(00)00109-5. MAGMA. 2000. PMID: 11186983 No abstract available.
[31P magnetic-resonance spectroscopy in cardiac diseases].
Mazaev VV, Stukalova OV, Ternovoĭ SK, Chazova IE. Mazaev VV, et al. Kardiologiia. 2012;52(3):67-73. Kardiologiia. 2012. PMID: 22839445 Review. Russian.
[Magnetic resonance tomography imaging techniques for diagnosing myocardial vitality].
Baer FM, Theissen P, Schneider CA, Voth E, Schicha H, Sechtem U. Baer FM, et al. Herz. 1994 Feb;19(1):51-64. Herz. 1994. PMID: 8150414 Review. German.

See all similar articles

Cited by

Myocardial perfusion imaging: clinical experience and recent progress in radionuclide scintigraphy and magnetic resonance imaging.
Keijer JT, Bax JJ, van Rossum AC, Visser FC, Visser CA. Keijer JT, et al. Int J Card Imaging. 1997 Oct;13(5):415-31. doi: 10.1023/a:1005737725964. Int J Card Imaging. 1997. PMID: 9360178 Review.
Methodological advances in cardiac 31P-MR spectroscopy.
von Kienlin M. von Kienlin M. MAGMA. 2000 Nov;11(1-2):36-8. doi: 10.1016/s1352-8661(00)00106-x. MAGMA. 2000. PMID: 11186980 No abstract available.
Evaluation of myocardial viability in chronic ischemic cardiomyopathy.
Bax JJ, van der Wall EE. Bax JJ, et al. Int J Cardiovasc Imaging. 2003 Apr;19(2):137-40. doi: 10.1023/a:1022882202305. Int J Cardiovasc Imaging. 2003. PMID: 12749394 No abstract available.
Human cardiac MR spectroscopy--clinical methods and applications.
Beer M, Hahn D, Neubauer S. Beer M, et al. MAGMA. 1998 Sep;6(2-3):113-5. MAGMA. 1998. PMID: 9803378 Review. No abstract available.
The future of real-time cardiac magnetic resonance imaging.
Nayak KS, Hu BS. Nayak KS, et al. Curr Cardiol Rep. 2005 Jan;7(1):45-51. doi: 10.1007/s11886-005-0010-x. Curr Cardiol Rep. 2005. PMID: 15610648 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.